Cassandra Kelly-cirino
Department of AMR & Outbreaks
Foundation for Innovative New Diagnostics (FIND)
Switzerland
Biography
Dr Cassandra Kelly-Cirino has over 20 years of experience working in Canadian and US public health and private sector settings. Cassandra began her career at the Canadian National Microbiology Laboratory working on emerging infectious diseases, including bacteria, viruses and prions.
Research Interest
Infectious diseases, Immunotherapeutics, Tuberculosis
Publications
-
Kelly-Cirino, C. D., Curry, P. S., Marola, J. L., Helstrom, N. K., & Salfinger, M. (2016). Novel multi-day sputum transport reagent works with routine tuberculosis tests and eliminates need for cold chain: Preliminary study of compatibility with the Xpert® MTB/RIF assay. Diagnostic microbiology and infectious disease, 86(3), 273-276.
-
Maharjan, B., Kelly-Cirino, C. D., Weirich, A., Curry, P. S., Hoffman, H., Avsar, K., & Shrestha, B. (2016). Evaluation of OMNIgene®• SPUTUM-stabilised sputum for long-term transport and Xpert® MTB/RIF testing in Nepal. The International Journal of Tuberculosis and Lung Disease, 20(12), 1661-1667.
-
Kelly-Cirino, C. D., Musisi, E., Byanyima, P., Kaswabuli, S., Andama, A., Sessolo, A., ... & Huang, L. (2017). Investigation of OMNIgene· SPUTUM performance in delayed tuberculosis testing by smear, culture, and Xpert MTB/RIF assays in Uganda. Journal of Epidemiology and Global Health, 7(2), 103-109.
